The UK BioIndustry Association has welcomed the launch of what is being described as the world’s largest randomized clinical trial of potential COVID-19 treatments, saying that the RECOVERY study shows that the UK is becoming a “powerhouse” in understanding the disease and will help to attract global companies to run major trials in the UK.
As of April 3, almost 1,000 patients from 132 hospitals had been recruited in just 15 days, and thousands more are expected to join the trial over the next few weeks